The female upper reproductive tract harbors endogenous microbial profiles

Front Endocrinol (Lausanne). 2023 Jun 21:14:1096050. doi: 10.3389/fendo.2023.1096050. eCollection 2023.

Abstract

Introduction: The female reproductive tract harbours unique microbial communities (known as microbiota) which have been associated with reproductive functions in health and disease. While endometrial microbiome studies have shown that the uterus possesses higher bacterial diversity and richness compared to the vagina, the knowledge regarding the composition of the Fallopian tubes (FT) is lacking, especially in fertile women without any underlying conditions.

Methods: To address this gap, our study included 19 patients who underwent abdominal hysterectomy for benign uterine pathology, and 5 women who underwent tubal ligation as a permanent contraceptive method at Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA). We analyzed the microbiome of samples collected from the FT and endometrium using 16S rRNA gene sequencing.

Results: Our findings revealed distinct microbiome profiles in the endometrial and FT samples, indicating that the upper reproductive tract harbors an endogenous microbiome. However, these two sites also shared some similarities, with 69% of the detected taxa Being common to both. Interestingly, we identified seventeen bacterial taxa exclusively present in the FT samples, including the genera Enhydrobacter, Granulicatella, Haemophilus, Rhizobium, Alistipes, and Paracoccus, among others. On the other hand, 10 bacterial taxa were only found in the endometrium, including the genera Klebsiella, Olsenella, Oscillibacter and Veillonella (FDR <0.05). Furthermore, our study highlighted the influence of the endometrial collection method on the findings. Samples obtained transcervically showed a dominance of the genus Lactobacillus, which may indicate potential vaginal contamination. In contrast, uterine samples obtained through hysterescopy revealed higher abundance of the genera Acinetobacter, Arthrobacter, Coprococcus, Methylobacterium, Prevotella, Roseburia, Staphylococcus, and Streptococcus.

Discussion: Although the upper reproductive tract appears to have a low microbial biomass, our results suggest that the endometrial and FT microbiome is unique to each individual. In fact, samples obtained from the same individual showed more microbial similarity between the endometrium and FT compared to samples from different women. Understanding the composition of the female upper reproductive microbiome provides valuable insights into the natural microenvironment where processes such as oocyte fertilization, embryo development and implantation occur. This knowledge can improve in vitro fertilization and embryo culture conditions for the treatment of infertility.

Keywords: 16S rRNA gene; endometrium; fallopian tubes; microbes; microbiome; microbiota; upper reproductive tract.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteria / genetics
  • Endometrium
  • Female
  • Humans
  • Infertility*
  • RNA, Ribosomal, 16S / genetics
  • Uterus*
  • Vagina / microbiology

Substances

  • RNA, Ribosomal, 16S

Grants and funding

This study was funded by FEDER/Junta de Andalucía-Consejería de Transformación Económica, Industrial, Conocimiento y Universidades/Proyectos (IRENE P20_00158, and ROBIN A-CTS-614-UGR20); the European Union, Horizon 2020 Marie Sklodowska-Curie Action, REPBIOTECH 675526, the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (AGL 2015-66341-R), Fundación Séneca 20040/GERM/1. ACG is funded by Plan de Recuperación, Transformación y resiliencia, Ayudas para la recualificación del sistema universitário español, Ayudas Margarita Salas para la formación de jóvenes doctores – Universidad de Murcia. IP-P is funded by FPU19/05561 funded by MCIN/AEI/10.13039/501100011033 and by ESF Investing in your future. ILB was funded by Grant GARANTIA JUVENIL ref. 8066 funded by AEI/10.13039/501100011033 and by ESF Investing in your future.ET is funded by Plataformas ISCIII de apoyo a la I+D+I en Biomedicina y Ciencias de la Salud (PT20700109). SA is funded by Spanish Ministry of Economy, Industry and Competitiveness (MINECO) and European Regional Development Fund (FEDER), by MCIN/AEI/10.13039/501100011033 and ERFD A way of making Europe Grants RYC-2016-21199, Grants Endo-Map PID2021-12728OB-100 and ENDORE SAF2017-87526-R and PID2021-127280OB-I00.